Publications by authors named "L Engelholm"

Claim this Profile
T
Targeting uPARAP with an antibody-drug conjugate exhibits efficacy against mesothelioma and synergizes with cisplatin.
Pınar Çakılkaya, Ida Marie Egeland Larsen, Qun Jiang, Kirstine Sandal Nørregaard, Henrik Gårdsvoll, Lars Henning Engelholm

Cancer Res Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β-adrenergic signaling blockade attenuates metastasis through activation of cytotoxic CD4 T cells.
Klaire Yixin Fjæstad, Astrid Zedlitz Johansen, Hannes Linder, Kevin James Baker, Milou Schattefor, Lars Henning Engelholm

Nat Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The recycling collagen receptor uPARAP is a unique mediator of stromal drug delivery to carcinoma cells.
Kirstine S Nørregaard, Ida M E Larsen, Henrik J Jürgensen, Michaela Hansen Blomquist, Pınar Çakılkaya, Lars H Engelholm

Mol Cancer Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting uPAR with an antibody-drug conjugate suppresses tumor growth and reshapes the immune landscape in pancreatic cancer models.
Virginia Metrangolo, Michaela Hansen Blomquist, Ananya Dutta, Henrik GÃ¥rdsvoll, Oliver Krigslund, Lars H Engelholm

Sci Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A HER2 Specific Nanobody-Drug Conjugate: Site-Selective Bioconjugation and In Vitro Evaluation in Breast Cancer Models.
Anders H Hansen, Kasper I H Andersen, Li Xin, Oliver Krigslund, Niels Behrendt, Lars H Engelholm

Molecules· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis